Featured Articles
Analysis
What Oregon’s Measure 109 Means for Hopeful Entrepreneurs and Investors
While entrepreneurs and investors are likely to see Oregon’s Measure 109 as a chance to capitalize on new business opportunities and investments, it’s worth highlighting that this new law is unlikely to lead to a psilocybin gold rush.
Press
Psyence Group Launches its Functional Mushroom Brand, “Goodmind”
Psyence Group Inc. announced it has launched its functional mushroom brand, “GOODMIND”
Press
Cybin Inc. Announces Uplisting to OTCQB Venture Market
Cybin Inc. today announced its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market.
Press
atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round
Quick Take The Series D fundraising saw participation from existing and new investors including Fearless Ventures, Falcon Edge…
Interview
Investing in Psychedelic Medicine and Sustainable Solutions for Mental Health and Well Being
To learn more about what the fund is building and where it sees the future going in the…
Press
TheraPsil Launches Beta Version of Psilocybin Therapy Training Program
TheraPsil announced the launch of its Health-Canada-approved, phase 1 psilocybin therapy training program for healthcare professionals.
Track the entire psychedelic market using the only index that covers the entire psychedelics marketplace.
Explore the IndexAll Articles
- All
- Analysis
- Interviews
- Press